ReviewBMC medicine2026
The role of continuous glucose monitoring for diagnosis of gestational diabetes: exploring the potential.
Review in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnosis of gestational diabetes relies upon an oral glucose tolerance test which has established limitations and suboptimal levels of patient adherence. Despite use of different diagnostic criteria globally, rates of GDM are increasing in line with increasing rates of obesity. There is a clinical need to establish an alternative methodology to diagnose GDM. Recent studies have examined the diagnostic role of continuous glucose monitoring with particular emphasis on glucometrics that correlate with adverse pregnancy outcome and may indicate CGM-based diagnostic thresholds for GDM. Additionally, CGM metrics associated with pharmacotherapy necessity have been identified. Given this work is observational and non-interventional, more robust data in the form of randomised control trials are required. Identification of diagnostic thresholds for GDM diagnosis will likely be outcome based and rely on a large international multicentre analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.